The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

One significant issue in the industry is the expiration of drugs before they can be used, leading to substantial financial losses and environmental harm. AI-optimised inventory management systems ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

In this report, 75% (43 of 57 patients) of patients with AV block caused by drugs had blocks at the level of the AV node. In addition, infranodal block was revealed in only 14% (eight of 57 ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.